Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (61 ops.)
Latest filing published 14 Aug 2026 for Denali Therapeutics Inc.. Read the official filing
Filing timeline
BuySaleRyan J. Watts
Insider track record
Disclosed buys
0
Disclosed sells
61
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ryan J. Watts: trading record in brief
This profile gathers the share dealings of Ryan J. Watts in Denali Therapeutics Inc., where the filings describe the role as chief executive. We count 81 filings; the first trade dates from 12 December 2017 and the latest from 12 August 2026.
The open-market record consists of 61 sales worth €11.0M, with no purchase. Other entries cover 6 share grants and 7 option exercises. Since January 2026: no purchases and 1 sale on the market.
The record was last updated on 14 August 2026 with a transaction in Denali Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ryan J. Watts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
32,220 shares0Common StockSEC:0001724310-26-000007:0
35,198 shares@ US$16.508.2% of flowCommon StockSEC:0001724310-26-000004:0
78,960 shares0Common StockSEC:0001724310-26-000001:0
50,000 shares0Common StockSEC:0001724310-25-000005:0
455,282 shares@ US$0.684.7% of flowCommon StockSEC:0001714899-25-000149:0
29,266 shares@ US$20.226.8% of flowCommon StockSEC:0001714899-25-000049:0
54,180 shares0Common StockSEC:0001714899-25-000028:0
40,000 shares@ US$0.680.3% of flowCommon StockSEC:0001714899-24-000206:0
2,260 shares@ US$23.790.6% of flowCommon StockSEC:0001714899-24-000197:0
40,000 shares0Common StockSEC:0001714899-24-000097:0
9,589 shares@ US$17.291.8% of flowCommon StockSEC:0001714899-24-000061:0
7,818 shares@ US$19.781.7% of flowCommon StockSEC:0001714899-24-000039:0
17,483 shares@ US$19.433.7% of flowCommon StockSEC:0001714899-24-000035:0
89,520 shares0Common StockSEC:0001714899-24-000008:0
2,309 shares@ US$22.590.6% of flowCommon StockSEC:0001714899-23-000133:0
2,526 shares@ US$0.680.0% of flowCommon StockSEC:0001714899-23-000123:0
50,000 shares@ US$0.680.4% of flowCommon StockSEC:0001714899-23-000105:0
200 shares@ US$0.680.0% of flowCommon StockSEC:0001714899-23-000066:0
8,815 shares@ US$30.092.9% of flowCommon StockSEC:0001714899-23-000029:0
3,433 shares@ US$30.591.2% of flowCommon StockSEC:0001714899-23-000023:0
4,800 shares@ US$28.441.5% of flowCommon StockSEC:0001714899-23-000013:0
82,240 shares0Common StockSEC:0001209191-23-002179:0
2,404 shares@ US$33.220.9% of flowCommon StockSEC:0001714899-22-000129:0
9,491 shares@ US$34.724.8% of flowCommon StockSEC:0001714899-22-000042:0
2,719 shares@ US$37.55191.5% of flowCommon StockSEC:0001714899-22-000035:0
25 of 36 declarations
